Literature DB >> 16188813

Cerebral blood flow and morphological changes after hypoxic-ischaemic injury in preterm lambs.

Enrique Hilario1, Mari Carmen Rey-Santano, Felipe Goñi-de-Cerio, Francisco Jose Alvarez, Elena Gastiasoro, Victoria Eugenia Mielgo, Amale Caballero, Adolfo Valls-i-Soler, Sonia Gómez-Urquijo, Antonia Alvarez.   

Abstract

AIM: To evaluate the effect of cerebral hypoxia-ischaemia induced by partial occlusion of the umbilical cord on the relationship of the regional cerebral blood flow and the cerebral cell death in near-term fetal lambs.
METHODS: Fifteen near-term lambs were assigned to two hypoxic-ischaemic groups with or without life support (3 h), and a healthy one. Hypoxia-ischaemia was induced by partial occlusion of the umbilical cord (60 min). Routine light and electron microscopy, and the TUNEL method for apoptosis were performed. Regional cerebral blood flow was measured by coloured microspheres. Cardiovascular, gas exchange and pH parameters were also evaluated.
RESULTS: Both hypoxic-ischaemic groups produced a transient acidosis and a decrease of base excess in comparison to the healthy group. Cortical and cerebellar zones, where the regional cerebral blood flow values were similar to baseline, showed an increased number of oligodendrocyte-like apoptotic cells. In contrast, in the inner zones, where regional cerebral blood flow was increased, the number of apoptotic cells did not increase. Necrotic neurons were observed in the basal nuclei, mesencephalon, pons and deep cerebellar nuclei.
CONCLUSION: Our results suggest that regional cerebral blood flow and the presence of apoptotic cells, 3 h after hypoxic-ischemic injury, are correlated.

Entities:  

Mesh:

Year:  2005        PMID: 16188813     DOI: 10.1111/j.1651-2227.2005.tb02009.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  7 in total

1.  Differential effect of intrauterine hypoxia on caspase 3 and DNA fragmentation in fetal guinea pig hearts and brains.

Authors:  LaShauna C Evans; Hongshan Liu; Loren P Thompson
Journal:  Reprod Sci       Date:  2012-03       Impact factor: 3.060

2.  The cannabinoid WIN 55212-2 mitigates apoptosis and mitochondrial dysfunction after hypoxia ischemia.

Authors:  D Alonso-Alconada; A Alvarez; F J Alvarez; J A Martínez-Orgado; E Hilario
Journal:  Neurochem Res       Date:  2011-09-11       Impact factor: 3.996

Review 3.  Cannabinoid as a neuroprotective strategy in perinatal hypoxic-ischemic injury.

Authors:  Daniel Alonso-Alconada; Antonia Alvarez; Enrique Hilario
Journal:  Neurosci Bull       Date:  2011-08       Impact factor: 5.203

4.  Characterization of Gene Expression in the Rat Brainstem After Neonatal Hypoxic-Ischemic Injury and Antioxidant Treatment.

Authors:  M Revuelta; O Arteaga; A Alvarez; A Martinez-Ibargüen; E Hilario
Journal:  Mol Neurobiol       Date:  2016-01-25       Impact factor: 5.590

5.  Effect of neonatal asphyxia on the impairment of the auditory pathway by recording auditory brainstem responses in newborn piglets: a new experimentation model to study the perinatal hypoxic-ischemic damage on the auditory system.

Authors:  Francisco Jose Alvarez; Miren Revuelta; Francisco Santaolalla; Antonia Alvarez; Hector Lafuente; Olatz Arteaga; Daniel Alonso-Alconada; Ana Sanchez-del-Rey; Enrique Hilario; Agustin Martinez-Ibargüen
Journal:  PLoS One       Date:  2015-05-26       Impact factor: 3.240

6.  Cannabinoid-mediated Modulation of Oxidative Stress and Early Inflammatory Response after Hypoxia-Ischemia.

Authors:  Daniel Alonso-Alconada; Francisco José Álvarez; Felipe Goñi-de-Cerio; Enrique Hilario; Antonia Álvarez
Journal:  Int J Mol Sci       Date:  2020-02-14       Impact factor: 5.923

7.  Pretreatment with Resveratrol Prevents Neuronal Injury and Cognitive Deficits Induced by Perinatal Hypoxia-Ischemia in Rats.

Authors:  Olatz Arteaga; Miren Revuelta; Leyre Urigüen; Antonia Álvarez; Haizea Montalvo; Enrique Hilario
Journal:  PLoS One       Date:  2015-11-06       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.